Product Wiki · Recalls · EU Safety Gate (RAPEX)

Lightening Program For Men- Cream Formula — recall A12/0778/13

EU Safety Gate (RAPEX) · Portugal · 2013-06-28 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
A12/0778/13
Date of alert
2013-06-28
Country / jurisdiction
Portugal
Risk level
Serious risk
Risk type
Chemical
Brand
Clairmen
Product category
Cosmetics
Product type
Skin lightening product
Reported risk: O produto apresenta um risco químico porque contém o ingrediente hidroquinona, cuja utilização é proibida em cosméticos e produtos de higiene pessoal. O produto não está em conformidade com a Diretiva de Cosméticos 76/768/CEE.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Other
Category of measure
Import rejected at border
Date of entry into force
04/06/2013
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Lightening Program For Men- Cream Formula

Risk Description (original English): The product poses a chemical risk because it contains the ingredient hydroquinone, the use of which is prohibited in cosmetics and personal hygiene products. The product does not comply with the Cosmetics Directive 76/768/EEC.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/73900

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.